10times
09 Oct 2020Ended

mAb Industry in China: Biosimilars vs Innovative Biologics

About 2SpeakersExhibitorsReviewsPhotos

Timings

09:00 AM - 06:00 PM
Not Verified

Official Links

Estimated Turnout

100 - 500
Delegates
Based on previous editions

Editions

09 Oct 2020

Frequency

Not Available
Claim event to edit details

mAb Industry in China: Biosimilars vs Innovative Biologics is creating huge potential for biosimilars, prompting innovators to shift their focus to .. Read more target more emerging markets which remain untapped for many companies. In this presentation, Joe will be sharing with you his vision of the biosimilars market with a focus on China. He will also discuss key considerations for mAb and biologics therapeutic development, providing a broad overview of challenges and opportunities presenting in the market.

Speaker
Dr Joe X Zhou

Dr Joe X Zhou

CEO at Genor Biopharma, Walvax Bio Group
Speaker
Sarah (Xuyu) Wang

Sarah (Xuyu) Wang

Head of Segment Marketing, Biosimilars and Bioconjugations at Sartorius Stedim...
  • Followers
  • [ Users who have shown interest for this Event ]
sds

sds

Lecturer at dfd

Slough, United Kingdom
  • Share your Experience
  • Organizer
Logo Follow Company

BIOPHARMA ASIA MAGAZINE

South Korea 50 Total Events / 18 Upcoming Events

More Events From The Organizer